Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2011, Article ID 545267, 8 pages
http://dx.doi.org/10.1155/2011/545267
Case Report

Early Experience of Helical Tomotherapy for Hepatobiliary Radiotherapy

1Department of Radiation Oncology and Medical Physics, Institut Curie, 75005 Paris, France
2Department of Radiation Oncology, Institut Claudius Regaud, 31052 Toulouse, France
3Department of Radiology, Institut Curie, 75005 Paris, France
4Department of Radiation Oncology, European Georges Pompidou Hospital, 75015 Paris, Paris Descartes University, 75005 Paris, France

Received 14 April 2011; Accepted 14 May 2011

Academic Editors: A. Irisawa, C. Karaca, and B. Mauro

Copyright © 2011 Carole Massabeau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Llovet, A. Burroughs, and J. Bruix, “Hepatocellular carcinoma: review,” The Lancet, vol. 362, no. 9399, pp. 1907–1917, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. B. Nordlinger and P. Rougier, “Liver metastases from colorectal cancer: the turning point,” Journal of Clinical Oncology, vol. 20, no. 6, pp. 1442–1445, 2002. View at Google Scholar · View at Scopus
  3. B. Nordlinger and P. Rougier, “Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation, and infusional treatment: what' s new in 2001?” Current Opinion in Oncology, vol. 14, no. 4, pp. 420–423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Emami, J. Lyman, A. Brown et al., “Tolerance of normal tissue to therapeutic irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 21, no. 1, pp. 109–122, 1991. View at Google Scholar · View at Scopus
  5. G. B. Stillwagon, S. E. Order, C. Guse et al., “194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a radiation therapy oncology group study,” International Journal of Radiation Oncology Biology Physics, vol. 17, no. 6, pp. 1223–1229, 1989. View at Google Scholar · View at Scopus
  6. M. A. Hawkins and L. A. Dawson, “Radiation therapy for hepatocellular carcinoma: from palliation to cure,” Cancer, vol. 106, no. 8, pp. 1653–1663, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. J. C. Cheng, J. K. Wu, C. M. Huang et al., “Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 1, pp. 156–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. A. Dawson, D. Normolle, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, “Analysis of radiation-induced liver disease using the lyman NTCP model,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 4, pp. 810–821, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Greco, G. Catalano, A. Di Grazia, and R. Orecchia, “Radiotherapy of liver malignancies. From whole liver irradiation to stereotactic hypofractionated radiotherapy,” Tumori, vol. 90, no. 1, pp. 73–79, 2004. View at Google Scholar · View at Scopus
  10. J. C. Cheng, J. K. Wu, C. M. Huang et al., “Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description,” Radiotherapy and Oncology, vol. 63, no. 1, pp. 41–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Dejean, G. Kantor, B. Henriques de Figueiredo et al., “Helical tomotherapy: description and clinical applications,” Bulletin du Cancer, vol. 97, no. 7, pp. 783–789, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. P. Giraud, M. Henni, and M. Housset, “Modern methods for cancer external radiation therapies,” Revue du Praticien, vol. 58, no. 15, pp. 1637–1640, 2008. View at Google Scholar · View at Scopus
  13. J. W. Jang, C. S. Kay, C. R. You et al., “Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 2, pp. 412–418, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. Das, R. A. Wolff, J. L. Abbruzzese et al., “Concurrent capecitabine and upper abdominal radiation therapy is well tolerated,” Radiation Oncology, vol. 1, article 41, 2006. View at Publisher · View at Google Scholar · View at PubMed
  15. C. Pan, B. Kavanagh, and L. Dawson, “Radiation-associated liver injury,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, supplement, pp. S94–S100, 2010. View at Publisher · View at Google Scholar · View at PubMed
  16. D. Azria, J. P. Gerard, G. Grehange et al., Société Française de Radiothérapie Oncologique-Guide des procédures de Radiothérapie Externe, 2007.
  17. V. S. Khoo and D. L. Joon, “New developments in MRI for target volume delineation in radiotherapy,” British Journal of Radiology, vol. 79, pp. S2–S15, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. G. Kantor, M. A. Mahé, P. Giraud et al., “French national evaluation for helicoidal tomotherapy: description of indications, dose constraints and set-up margins,” Cancer Radiotherapie, vol. 11, no. 6-7, pp. 331–337, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. K. K. Herfarth, J. Debus, F. Lohr et al., “Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases,” International Journal of Radiation Oncology Biology Physics, vol. 46, no. 2, pp. 329–335, 2000. View at Publisher · View at Google Scholar
  20. International Commission on Radiation Units and Measurements, “Prescribing, recording and reporting photon beam therapy,” Report 62 (Supplement to ICRU Report 50), ICRU, Bethesda, Md, USA, 1999. View at Google Scholar
  21. A. Jackson, L. B. Marks, S. M. Bentzen et al., “The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome,” International Journal of Radiation Oncology Biology Physics, vol. 76, no. 3, supplement, pp. S155–S160, 2010. View at Publisher · View at Google Scholar · View at PubMed
  22. S. J. Shim, J. Seong, I. J. Lee, K. H. Han, C. Y. Chon, and S. H. Ahn, “Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma,” Hepatology Research, vol. 37, no. 11, pp. 906–913, 2007. View at Publisher · View at Google Scholar · View at PubMed
  23. Z. G. Ren, J. D. Zhao, K. Gu et al., “Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study,” International Journal of Radiation Oncology Biology Physics, vol. 79, no. 2, pp. 496–502, 2011. View at Publisher · View at Google Scholar · View at PubMed
  24. J. M. Baisden, A. G. Reish, K. Sheng, J. M. Larner, B. D. Kavanagh, and P. W. Read, “Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 2, pp. 620–625, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. Sherman and J. Bruix, “Management of hepatocellular carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. P. Venook, “Treatment of hepatocellular carcinoma: too many options?” Journal of Clinical Oncology, vol. 12, no. 6, pp. 1323–1334, 1994. View at Google Scholar · View at Scopus
  27. M. A. Hawkins and L. A. Dawson, “Radiation therapy for hepatocellular carcinoma,” Cancer, vol. 106, no. 8, pp. 1653–1663, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. L. A. Dawson, C. J. McGinn, D. Normolle et al., “Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies,” Journal of Clinical Oncology, vol. 18, no. 11, pp. 2210–2218, 2000. View at Google Scholar · View at Scopus
  29. J. Seong, H. C. Park, K. H. Han, and C. Y. Chon, “Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients,” International Journal of Radiation Oncology Biology Physics, vol. 55, no. 2, pp. 329–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Han, J. Seong, J. K. Kim et al., “Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis,” Cancer, vol. 113, no. 5, pp. 995–1003, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. E. Ben-Josef, D. Normolle, W. D. Ensminger et al., “Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8739–8747, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. A. McIntosh, K. D. Hagspiel, A. M. Al-Osaimi et al., “Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma,” Cancer, vol. 115, no. 21, pp. 5117–5125, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. K. Herfarth, J. Debus, F. Lohr et al., “Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial,” Journal of Clinical Oncology, vol. 19, no. 1, pp. 164–170, 2001. View at Google Scholar · View at Scopus
  34. R. V. Tse, M. Hawkins, G. Lockwood et al., “Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma,” Journal of Clinical Oncology, vol. 26, no. 4, pp. 657–664, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. T. E. Schefter, B. D. Kavanagh, R. D. Timmerman, H. R. Cardenes, A. Baron, and L. E. Gaspar, “A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 5, pp. 1371–1378, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. J. H. Kwon, S. H. Bae, J. Y. Kim et al., “Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. stereotactic radiotherapy for liver cancer,” BMC Cancer, vol. 10, article 475, 2010. View at Publisher · View at Google Scholar · View at PubMed
  37. C. Louis, S. Dewas, X. Mirabel et al., “Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results,” Technology in Cancer Research and Treatment, vol. 9, no. 5, pp. 479–487, 2010. View at Google Scholar · View at Scopus
  38. W. S. Koom, J. Seong, K. H. Han, D. Y. Lee, and J. T. Lee, “Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?” International Journal of Radiation Oncology Biology Physics, vol. 77, no. 5, pp. 1433–1440, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. T. Ruers and R. P. Bleichrodt, “Treatment of liver metastases, an update on the possibilities and results,” European Journal of Cancer, vol. 38, no. 7, pp. 1023–1033, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. J. K. Heimbach, G. J. Gores, M. G. Haddock et al., “Liver transplantation for unresectable perihilar cholangiocarcinoma,” Seminars in Liver Disease, vol. 24, no. 2, pp. 201–207, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. F. Eckel and R. M. Schmid, “Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials,” British Journal of Cancer, vol. 96, no. 6, pp. 896–902, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. T. A. Rich, D. B. Evans, S. A. Curley, and J. A. Ajani, “Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer,” Annals of Oncology, vol. 5, supplement 3, pp. 75–80, 1994. View at Google Scholar · View at Scopus
  43. M. A. Ben-David, K. A. Griffith, E. Abu-Isa et al., “External-beam radiotherapy for localized extrahepatic cholangiocarcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 3, pp. 772–779, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. M. F. Gerhards, T. M. van Gulik, D. González González, E. A. Rauws, and D. J. Gouma, “Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma,” World Journal of Surgery, vol. 27, no. 2, pp. 173–179, 2003. View at Google Scholar · View at Scopus
  45. J. M. Baisden, M. Kahaleh, G. R. Weiss et al., “Capecitabine, and photodynamic therapy is feasible and well tolerated in patients with hilar cholangiocarcinom,” Gastrointestinal Cancer Research, vol. 2, no. 5, pp. 219–224, 2008. View at Google Scholar
  46. D. J. Rea, J. K. Heimbach, C. B. Rosen et al., “Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma,” Annals of Surgery, vol. 242, no. 3, pp. 451–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. C. H. Crane, K. O. Macdonald, J. N. Vauthey et al., “Limitations of conventional doses of chemoradiation for unresectable biliary cancer,” International Journal of Radiation Oncology Biology Physics, vol. 53, no. 4, pp. 969–974, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Chargari, F. Campana, P. Beuzeboc, S. Zefkili, and Y. M. Kirova, “Preliminary experience of helical tomotherapy for locally advanced pancreatic cancer,” World Journal of Gastroenterology, vol. 15, no. 35, pp. 4444–4445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. J. S. Ji, C. W. Han, J. W. Jang et al., “Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer,” Radiation Oncology, vol. 5, article 60, 2010. View at Publisher · View at Google Scholar · View at PubMed
  50. J. Seong, H. C. Park, K. H. Han et al., “Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization,” International Journal of Radiation Oncology Biology Physics, vol. 47, no. 5, pp. 1331–1335, 2000. View at Publisher · View at Google Scholar · View at Scopus